Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 317 (ZNF317) is a human protein encoded by the ZNF317 gene that belongs to the large family of zinc finger transcription factors, specifically those with a KRAB domain. It is predicted to act as a transcription factor regulating the expression of target genes by binding to cis-regulatory DNA regions, with possible roles in erythroid cell maturation and lymphoid cell proliferation. While disorders such as female stress incontinence and frontometaphyseal dysplasia have been associated with this gene, there is no current evidence supporting its use as a therapeutic target or that drugs directly interact with it[2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 317 (ZNF317).